Accelerated biological aging increases the risk of short- and long-term stroke prognosis in patients with ischemic stroke or TIA

作者：Mengxing Wang, Hongyi Yan, Yanli Zhang, Qi Zhou, Xia Meng, Jinxi Lin, Yong Jiang, Yuesong Pan, Yongjun Wang · 发表于：EBioMedicine · 年份：2024 · DOI：10.1016/j.ebiom.2024.105494 · 被引用次数：29 · 研究领域：Acute Ischemic Stroke Management、Dementia and Cognitive Impairment Research、Frailty in Older Adults

BACKGROUND: Biological age (BA), an integrated measure of physiological aging, has a clear link to stroke. There is a paucity of long-term longitudinal studies about the association between accelerated biological age and stroke prognosis in patients with previous strokes, and the differences in the predictive ability of various BA indicators calculated from clinical biochemistry biomarkers for future stroke outcomes are still unknown. To evaluate the role of three accelerated BA indicators for short- and long-term prognosis of patients with ischemic stroke or transient ischemic attack (TIA), and to identify the most appropriate predictor. METHODS: This study included 7396 patients from the Third China National Stroke Registry (CNSR-III), a prospective national registry of patients with acute ischemic stroke or TIA between August 2015 and March 2018 in China. We constructed accelerated BA using three widely recognized algorithms: PhenoAge, Klemera-Doubal, and HD method. To ascertain the association of accelerated BA with the risk of short- and long-term stroke outcomes, a Cox or logistic regression model was conducted for the analysis. The net reclassification index and integrated discrimination improvement were used to evaluate the added model improvement ability of BA acceleration. FINDINGS: Compared to those with the lowest of PhenoAge acceleration, patients with the highest were more likely to have a higher risk of stroke (HR 1.98, 95% CI 1.49-2.63, P < 0.001), ischemic st...